A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants
Clinical trial NCT05184452 · COMPLETED
Trial details
- NCT number
- NCT05184452
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2023-07-19
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.